WASHINGTON (Reuters) – Multiple drug-resistant tuberculosis killed 150,000 people in 2008 and infects between 400,000 and 500,000 people globally, according to World Health Organization estimates released yesterday.

WHO said the numbers suggest the hard-to-treat infection is spreading and said there is an urgent need for countries to set up labs to fight it.

So-called MDR-TB is especially common in Russia, Tajikistan, China and India, WHO said in a report. It said an especially hard-to-treat form called extensively drug resistant TB or XDR-TB is also growing.

“Almost 50 percent of MDR-TB cases worldwide are estimated to occur in China and India. In 2008, MDR-TB caused an estimated 150,000 deaths,” the WHO report said.

The report uses new methods and new surveillance data from countries around the world, so the figures cannot be compared to older surveys of MDR-TB. But WHO said the findings are startling and show a need to find infected patients and treat them promptly.

Tuberculosis is caused by a type of bacteria called Mycobacterium tuberculosis. More than 2 billion people are infected but nearly all TB infections are latent, with carriers showing no symptoms and they are not infectious.

MORE IN Archives


Reader Comments »

The Comments section is intended to provide a forum for reasoned and reasonable debate on the newspaper's content and is an extension of the newspaper and what it has become well known for over its history: accuracy, balance and fairness.
  • We reserve the right to edit/delete comments which contain attacks on other users, slander, coarse language and profanity, and gratuitous and incendiary references to race and ethnicity.
  • We moderate ALL comments, so your comment will not be published until it has been reviewed by a moderator.
  • Our Comments are powered by the Disqus service. You may comment as a Guest by entering your comment and selecting "Post as". Optionally, you may sign-in using your Facebook, Yahoo or Twitter Accounts.

    Disqus' Privacy Policy can be read here. Please read our Terms of Service and Privacy Policy.